Treace Medical Concepts, Inc. has announced the limited market release of its new Percuplasty™ Percutaneous 3D Bunion Correction® System, following successful initial surgical cases.

Concepts announced the limited market release and first surgical cases utilizing the Percuplasty Percutaneous 3D Bunion ...

Internet Posting of Information Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages ...

It is important to know that these treatments do not get rid of the bunion or correct the deformity. The only way to get rid of the bump and straighten the toe is with a surgical correction.

Fintel reports that on December 31, 2024, Lake Street initiated coverage of Treace Medical Concepts (NasdaqGS:TMCI) with a ...

Dream Finders Home Inc. said in a Dec. 23 Securities and Exchange Commission filing that Chief Operations Officer Doug Moran ...

Geode Capital Management LLC trimmed its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 2.0% in the third quarter, according to its most recent Form 13F filing with ...

Genie Bouchard and other semi-boldfaced names are finding that tennis success doesn’t always translate to glory on a smaller ...

(“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its ...

PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace” or the "Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...

After hours: December 31 at 4:01:35 PM EST Loading Chart for TMCI ...

PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...